BioCentury
ARTICLE | Company News

Futura, Stada Arzneimittel deal

January 13, 2017 7:49 PM UTC

Futura granted Stada’s Thornton & Ross Ltd. subsidiary rights to commercialize pain candidate TPR100 in the U.K. Thornton & Ross will submit a regulatory application next half. Futura will receive an ...